{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:17:40Z","timestamp":1794716260215,"version":"4.9.1"},"reference-count":48,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Eosinophilic solid and cystic renal cell carcinoma is now defined in the 5th edition of the 2022 World Health Organization classification of urogenital tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To perform morphologic, immunohistochemical, and preliminary genetic studies about this new entity in China for the purpose of understanding it better.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>The study includes 18 patients from a regional tertiary oncology center in northern China (Tianjin, China). We investigated the clinical and immunohistochemical features of these cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>The mean age of patients was 49.6 years, and the male to female ratio was 11:7. Macroscopically, 1 case had the classic cystic and solid appearance, whereas the others appeared purely solid. Microscopically, all 18 tumors shared a similar solid and focal macrocystic or microcystic growth pattern, and the cells were characterized by voluminous and eosinophilic cytoplasm, along with coarse amphophilic stippling. Immunohistochemically, most of the tumors had a predominant cytokeratin (CK) 20\u2013positive feature, ranging from focal cytoplasmic staining to diffuse membranous accentuation. Initially, we separated these cases into different immunohistochemical phenotypes. Group 1 (7 of 18; 38.5%) was characterized by positive phospho-4EBP1 and phospho-S6, which can imply hyperactive mechanistic target of rapamycin complex 1 (mTORC1) signaling. Group 2 (4 of 18; 23%) was negative for NF2, probably implying a germline mutation of NF2. Group 3 (7 of 18; 38.5%) consisted of the remaining cases. One case had metastatic spread and exhibited an aggressive clinical course, and we detected cyclin-dependent kinase inhibitor 2A (CDKN2A) mutation in this case; other patients were alive and without disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Our research proposes that eosinophilic solid and cystic renal cell carcinoma exhibits prototypical pathologic features with CK20 positivity and has aggressive potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2023-0122-oa","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T03:50:39Z","timestamp":1706500239000},"page":"1126-1134","source":"Crossref","is-referenced-by-count":9,"title":["Eosinophilic Solid and Cystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Study of 18 Cases and Review of the Literature"],"prefix":"10.5858","volume":"148","author":[{"given":"Qianru","family":"Guo","sequence":"first","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yao","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Qi","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Wang","sequence":"additional","affiliation":[{"name":"the Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada (F. Wang)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Guo","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxue","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Cao","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalei","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmei","family":"Li","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujuan","family":"Huang","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxu","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyuan","family":"Qu","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Ren","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manlin","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Yan","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Meng","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[{"name":"the Department of Pathology and Laboratory Medicine, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada (C. Wang)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Cao","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Q. Guo, B. Yang, L. Qi, Y. Guo, Y. Liu, Z. Cao, Y. Wang, J Wang, L. Li, Q. Huang, C. Liu, T. Qu, W. Zhao, D. Ren, M. Yang, C. Yan, B. Meng, W. Cao) and Medical Oncology (X. Yao), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"issue":"12","key":"2024092423515936200_i1543-2165-148-10-1126-b01","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.5858\/arpa.2019-0203-RA","article-title":"Eosinophilic kidney tumors: old and new","volume":"143","author":"Iczkowski","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"2024092423515936200_i1543-2165-148-10-1126-b02","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part A: Renal, Penile, and Testicular Tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"issue":"1","key":"2024092423515936200_i1543-2165-148-10-1126-b03","first-page":"60","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study","volume":"40","author":"Trpkov","year":"2016","journal-title":"of 16 unique, sporadic neoplasms occurring in women. Am J Surg Pathol"},{"key":"2024092423515936200_i1543-2165-148-10-1126-b04","doi-asserted-by":"crossref","first-page":"13131","DOI":"10.1038\/ncomms13131","article-title":"Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"issue":"10","key":"2024092423515936200_i1543-2165-148-10-1126-b05","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2024092423515936200_i1543-2165-148-10-1126-b06","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/his.13457","article-title":"Eosinophilic solid and cystic renal cell carcinomas have metastatic potential","volume":"72","author":"McKenney","year":"2018","journal-title":"Histopathology"},{"key":"2024092423515936200_i1543-2165-148-10-1126-b07","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2018.05.023","article-title":"Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases","volume":"80","author":"Tretiakova","year":"2018","journal-title":"Hum Pathol"},{"issue":"7","key":"2024092423515936200_i1543-2165-148-10-1126-b08","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","article-title":"Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations","volume":"42","author":"Parilla","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"2024092423515936200_i1543-2165-148-10-1126-b09","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"2024092423515936200_i1543-2165-148-10-1126-b10","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.urology.2018.01.020","article-title":"Eosinophilic solid and cystic renal cell carcinoma: imaging features of a novel neoplasm","volume":"114","author":"Fenelon","year":"2018","journal-title":"Urology"},{"issue":"4","key":"2024092423515936200_i1543-2165-148-10-1126-b11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"issue":"11","key":"2024092423515936200_i1543-2165-148-10-1126-b12","first-page":"840","article-title":"Eosinophilic solid and cystic renal cell carcinoma: clinicopathological analysis and molecular characterization","volume":"48","author":"Xia","year":"2019","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"7","key":"2024092423515936200_i1543-2165-148-10-1126-b13","first-page":"693","article-title":"Eosinophilic solid and cystic renal cell carcinoma with TSC2 gene mutations in children","volume":"49","author":"Yang","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"7","key":"2024092423515936200_i1543-2165-148-10-1126-b14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/1066896921993229","article-title":"Two cases of sporadic eosinophilic solid and cystic renal cell carcinoma in Manitoba population","volume":"29","author":"Mohaghegh Poor","year":"2021","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"2024092423515936200_i1543-2165-148-10-1126-b15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","article-title":"Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"issue":"1","key":"2024092423515936200_i1543-2165-148-10-1126-b16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part A: Renal, Penile, and Testicular Tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"issue":"11","key":"2024092423515936200_i1543-2165-148-10-1126-b17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2024092423515936200_i1543-2165-148-10-1126-b18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2024092423515936200_i1543-2165-148-10-1126-b19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1066896909333510","article-title":"Distinctive morphology of renal cell carcinomas in tuberous sclerosis","volume":"18","author":"Schreiner","year":"2010","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"2024092423515936200_i1543-2165-148-10-1126-b20","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.tranon.2018.05.010","article-title":"Molecular characterization and putative pathogenic pathways of tuberous sclerosis complex-associated renal cell carcinoma","volume":"11","author":"Park","year":"2018","journal-title":"Transl Oncol"},{"issue":"1","key":"2024092423515936200_i1543-2165-148-10-1126-b21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00428-018-2468-0","article-title":"Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma","volume":"474","author":"Eich","year":"2019","journal-title":"Virchows Arch"},{"issue":"6","key":"2024092423515936200_i1543-2165-148-10-1126-b22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-2559.2010.03726.x","article-title":"Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features","volume":"57","author":"Trpkov","year":"2010","journal-title":"Histopathology"},{"issue":"6","key":"2024092423515936200_i1543-2165-148-10-1126-b23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2559.2004.02003.x","article-title":"Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray","volume":"45","author":"Abrahams","year":"2004","journal-title":"Histopathology"},{"issue":"11","key":"2024092423515936200_i1543-2165-148-10-1126-b24","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41379-019-0304-y","article-title":"Hybrid oncocytic\/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma","volume":"32","author":"Ruiz-Cordero","year":"2019","journal-title":"Mod Pathol"},{"issue":"2","key":"2024092423515936200_i1543-2165-148-10-1126-b25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/biomedicines11020245","article-title":"TFEB rearranged renal cell carcinoma: pathological and molecular characterization of 10 cases, with novel clinical implications: a single center 10-year experience","volume":"11","author":"Wang","year":"2013","journal-title":"Biomedicines"},{"issue":"1","key":"2024092423515936200_i1543-2165-148-10-1126-b26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2024092423515936200_i1543-2165-148-10-1126-b27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","article-title":"Eosinophilic renal cell tumors with a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous: clinicopathologic and molecular study","volume":"44","author":"Tjota","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"2024092423515936200_i1543-2165-148-10-1126-b28","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.febslet.2014.04.001","article-title":"Molecular insights into NF2\/Merlin tumor suppressor function","volume":"588","author":"Cooper","year":"2014","journal-title":"FEBS Lett"},{"issue":"5","key":"2024092423515936200_i1543-2165-148-10-1126-b29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2015.125","article-title":"Role of Merlin\/NF2 inactivation in tumor biology","volume":"35","author":"Petrilli","year":"2016","journal-title":"Oncogene"},{"key":"2024092423515936200_i1543-2165-148-10-1126-b30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J Rare Dis"},{"issue":"6429","key":"2024092423515936200_i1543-2165-148-10-1126-b31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"issue":"5","key":"2024092423515936200_i1543-2165-148-10-1126-b32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"72","author":"Trofatter","year":"1993","journal-title":"Cell"},{"issue":"11","key":"2024092423515936200_i1543-2165-148-10-1126-b33","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/carcin\/bgn200","article-title":"YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation","volume":"29","author":"Yokoyama","year":"2008","journal-title":"Carcinogenesis"},{"issue":"10","key":"2024092423515936200_i1543-2165-148-10-1126-b34","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1349-7006.1995.tb03003.x","article-title":"Low incidence of a nucleotide sequence alteration of the neurofibromatosis 2 gene in human breast cancers","volume":"86","author":"Yaegashi","year":"1995","journal-title":"Jpn J Cancer Res"},{"issue":"1","key":"2024092423515936200_i1543-2165-148-10-1126-b35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13402-013-0164-2","article-title":"Loss of NF2\/Merlin expression in advanced sporadic colorectal cancer","volume":"37","author":"Ca\u010dev","year":"2014","journal-title":"Cell Oncol (Dordr)"},{"issue":"291","key":"2024092423515936200_i1543-2165-148-10-1126-b36","doi-asserted-by":"crossref","first-page":"ra77","DOI":"10.1126\/scisignal.2004060","article-title":"The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis","volume":"6","author":"Yi","year":"2013","journal-title":"Sci Signal"},{"issue":"9","key":"2024092423515936200_i1543-2165-148-10-1126-b37","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4161\/cbt.25329","article-title":"Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17, and LPIN2 genes","volume":"14","author":"Malhotra","year":"2013","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"2024092423515936200_i1543-2165-148-10-1126-b38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck","year":"2015","journal-title":"Nat Genet"},{"issue":"3","key":"2024092423515936200_i1543-2165-148-10-1126-b39","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2015.06.019","article-title":"Characterization of clinical cases of collecting duct carcinoma of the kidney assessed by comprehensive genomic profiling","volume":"70","author":"Pal","year":"2016","journal-title":"Eur Urol"},{"issue":"4","key":"2024092423515936200_i1543-2165-148-10-1126-b40","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/jid.2012.401","article-title":"Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions","volume":"133","author":"Jenkins","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"5","key":"2024092423515936200_i1543-2165-148-10-1126-b41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.cej.0000236260.26265.d6","article-title":"Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking","volume":"16","author":"Georgiou","year":"2007","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"2024092423515936200_i1543-2165-148-10-1126-b42","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ijc.25432","article-title":"Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: cohort study and literature review","volume":"128","author":"Shima","year":"2011","journal-title":"Int J Cancer"},{"issue":"15","key":"2024092423515936200_i1543-2165-148-10-1126-b43","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199510123331504","article-title":"Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations","volume":"333","author":"Goldstein","year":"1995","journal-title":"N Engl J Med"},{"issue":"15","key":"2024092423515936200_i1543-2165-148-10-1126-b44","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","article-title":"High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families","volume":"92","author":"Borg","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2024092423515936200_i1543-2165-148-10-1126-b45","first-page":"235","article-title":"Detecting homozygous deletions in the CDKN2A (p16(INK4a))\/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR","volume":"9","author":"Berggren","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2024092423515936200_i1543-2165-148-10-1126-b46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/genes13050851","article-title":"A novel cuproptosis-related prognostic gene signature and validation of differential expression in clear cell renal cell carcinoma","volume":"13","author":"Bian","year":"2022","journal-title":"Genes (Basel)"},{"issue":"3","key":"2024092423515936200_i1543-2165-148-10-1126-b47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAS.0000000000001802","article-title":"Papillary renal cell carcinoma with microcystic architecture is strongly associated with extrarenal invasion and metastatic disease","volume":"46","author":"Chan","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"2024092423515936200_i1543-2165-148-10-1126-b48","doi-asserted-by":"crossref","first-page":"153453","DOI":"10.1016\/j.prp.2021.153453","article-title":"Mutant CDKN2A regulates P16\/p14 expression by alternative splicing in renal cell carcinoma metastasis","volume":"223","author":"Sun","year":"2021","journal-title":"Pathol Res Pract"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/10\/1126\/3431215\/i1543-2165-148-10-1126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/10\/1126\/3431215\/i1543-2165-148-10-1126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:01Z","timestamp":1764790801000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/148\/10\/article-p1126.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,1,29]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2023-0122-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}